Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Valeant Pharmaceuticals Intl (VRX) NYSE

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 5,329,780
  • Shares Outstanding, K 347,540
  • Annual Sales, $ 10,447 M
  • Annual Income, $ -292 M
  • 36-Month Beta -0.13
  • Price/Sales 0.53
  • Price/Book 1.25

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.81 +9.41%
on 12/28/16
17.55 -13.90%
on 01/10/17
+1.01 (+7.16%)
since 12/16/16
3-Month
13.00 +16.23%
on 12/15/16
24.30 -37.82%
on 11/01/16
-6.96 (-31.54%)
since 10/18/16
52-Week
13.00 +16.23%
on 12/15/16
101.40 -85.10%
on 02/02/16
-73.59 (-82.97%)
since 01/15/16

Most Recent Stories

More News
Healthcare Stocks Under Scanner -- Valeant Pharma, Alkermes, Universal Health Services, and LifePoint Health

On Thursday, January 12, 2017, the NASDAQ Composite ended the trading session at 5,547.49, down 0.29%; the Dow Jones Industrial Average edged 0.32% lower, to finish at 19,891; and the S&P 500 closed at...

Pharma Stock Roundup: Trump Targets Pharma Again, Merck Up on Keytruda News

The sector was once again slammed by president-elect Donald Trump's comments this week regarding drug pricing.

Deja Vu for Drug Stocks as Trump Slams Drug Pricing Again

Drug stocks were hit once again with President-elect Donald Trump's comments about the sector at his first news conference since his election in November.

Valeant Streamlines Portfolio with Skincare Brands Sale

Beleaguered Valeant Pharmaceuticals International, Inc. (VRX) announced that it has entered into an agreement to sell its CeraVe, AcneFree and AMBI skincare brands to L'Or??al for $1.3 billion in cash....

Latest Research Reports on Market Movers Valeant Pharmaceuticals and Chipotle Mexican Grill

NEW YORK, NY / ACCESSWIRE / January 11, 2017 / The Dow Jones Industrial Average dropped slightly Tuesday as the Index was dragged lower by declines from the energy sector. The Dow declined 31.85 points,...

Do Options Traders Know Something About Valeant Pharmaceuticals (VRX) Stock We Don't?

Valeant Pharmaceuticals (VRX) warrants investors' attention based on moves in the options market lately.

Blog Coverage Valeant Sells-Off Its Skin Care Brands to L'Oreal

Upcoming AWS Coverage on Alkermes

Williams and Ascena Retail sink while Illumina, Valeant jump

NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday:

Valeant to Sell Dendreon Unit to Sanpower for $820 Million

Beleaguered Valeant Pharmaceuticals International, Inc. (VRX) announced that it will sell all the outstanding equity interests in Dendreon Pharmaceuticals, Inc. to the China based Sanpower Group Co., Ltd....

Valeant sells $2B in assets to begin paying down debt

NEW YORK (AP) — Valeant will sell just over $2 billion in assets as it pays down debts after a year and a half of bruising backlash against some of its drug prices and government probes into the way...

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Valeant Pharmaceuticals International, Inc. is a pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics. The Company produces medicines that meet the special health problems of patients....

See More

Support & Resistance

2nd Resistance Point 15.74
1st Resistance Point 15.43
Last Price 15.11
1st Support Level 14.79
2nd Support Level 14.46

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.